Question explored with the scientific record
Do statins reduce strokes?
Statins reduce the risk of stroke in people who already have cardiovascular disease, but the benefit for people without existing disease is smaller and less certain.
The strongest evidence comes from a 2003 meta-analysis of 38 randomized trials covering over 83,000 patients. It found that statins cut stroke risk by about 26% in people with coronary artery disease [1]. But the benefit was limited to people whose cholesterol was above a threshold of about 232 mg/dL [1]. For every 735 people treated, one stroke was prevented [1]. That is a large number needed to treat.
The same meta-analysis found that statins did not reduce fatal strokes (relative risk 1.09, confidence interval 0.86–1.38) or hemorrhagic strokes (relative risk 1.16, confidence interval 0.75–1.80) [1]. The benefit was entirely in non-fatal, ischemic strokes.
| Population | Stroke risk reduction | Key limitation |
|---|---|---|
| People with existing coronary disease | 26% relative reduction [1] | No benefit for fatal or hemorrhagic stroke |
| People after a first stroke (secondary prevention) | 7.5% vs 16.3% recurrence over 10 years [2] | Single study, 794 patients |
| Primary prevention (no existing disease) | Smaller or uncertain | Benefit only above cholesterol threshold [1] |
For people who have already had a stroke, continuing statin therapy matters. A 2009 study of 794 first-stroke survivors found that those on statins had a 7.5% recurrence rate over 10 years versus 16.3% for those not on statins [2]. A 2007 study found that stopping statins after a stroke was linked to a nearly threefold higher risk of death within a year [3].
The evidence for primary prevention—giving statins to healthy people to prevent a first stroke—is much weaker. The meta-analysis found no benefit for people with cholesterol below 232 mg/dL [1]. A 2024 review of older adults found that in people over 75 without known vascular disease, statins did not significantly reduce major vascular events [4].
My call: for someone with established heart disease or a prior stroke, statins reduce the chance of another non-fatal stroke. For a healthy person without those conditions, the evidence does not support taking a statin to prevent a first stroke. Confidence: moderate.
Sources used 4
-
Differential Effects of Lipid-Lowering Therapies on Stroke Prevention
This meta-analysis of 38 randomized trials (83,161 patients) shows lipid-lowering therapies reduce stroke incidence in coronary patients, with statins providing the largest benefit, and identifies a final cholesterol threshold around 232 mg/dL below which stroke risk reduction b…
DOI: 10.1001/archinte.163.6.669 -
Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival
This study investigates the impact of statin therapy on the recurrence of ischemic stroke and long-term mortality in patients who experienced a first-ever stroke, finding that statin use significantly reduces both stroke recurrence and mortality over a 10-year period.
DOI: 10.1212/wnl.0b013e3181a711cb -
Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke
In a prospective cohort of 631 ischemic stroke survivors without coronary heart disease discharged on statins, 38.9% discontinued statins within 12 months, and discontinuation was independently associated with higher all-cause 1-year mortality (HR 2.78).
DOI: 10.1161/strokeaha.107.487017 -
Statin Therapy for Primary and Secondary Prevention in Older Adults
Evidence supports statin therapy for secondary prevention in older adults and for primary prevention in selected high-risk older patients; age alone should not deter statin therapy.
DOI: 10.1007/s11883-024-01257-9